Live Breaking News & Updates on Valeria fantin

Stay updated with breaking news from Valeria fantin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi

19.12.2023 - Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) and Sanofi (NASDAQ: SNY) announced today that Sanofi has exercised its option to license a natural killer (NK) cell engager program in solid tumors from Innate’s ANKET ... Seite 1

Valeria-fantin , Global-head-of-oncology-research-at-sanofi , Global-head , Oncology-research , Engager-therapeutics , Innate-pharma-aktie , Nnate-pharma-spons-ads-aktie ,

Innate Pharma (IPHA) Reports Publication of Preclinical Data with a Trifunctional NK Cell Engager in Acute Myeloid Leukemia

Innate Pharma (IPHA) Reports Publication of Preclinical Data with a Trifunctional NK Cell Engager in Acute Myeloid Leukemia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France , French , Arthur-rouill , Henry-wheeler , Valeria-fantin , Eric-vivier , Bristol-myers-squibb , Novo-nordisk , Company-annual-report-on-form , French-financial-markets-authority , Exchange-commission , Astrazeneca

Sanofi and Innate Pharma expand cancer therapeutics collaboration

Sanofi and Innate Pharma expand cancer therapeutics collaboration
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

France , French , Valeria-fantin , Innate-pharma , Cell-engager-therapeutics , Yannis-morel ,

Sanofi to license Innate Pharma's NK cell platform

Sanofi will license Innate Pharma’s B7H3 ANKET platform, which is creating a new class of molecules to induce synthetic cancer immunity.

Valeria-fantin , Global-head-of-oncology-research-at-sanofi , Innate-pharma , Natural-killer-cell , Engager-therapeutics , Global-head , Oncology-research , Executive-vice-president , Innate-pharmaceutical ,

Press Release: Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology

Press Release: Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Paris , France-general- , France , French , Sanofimedia-relationssandrine-guendoul , Corentine-driancourt , Felix-lauscher , Valeria-fantin , Relationseva-schaefer-jansen , Kate-conway , Bristol-myers-squibb , Pharmainnate-pharma

Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology

Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France , French , Eva-schaefer-jansen , Corentine-driancourt , Valeria-fantin , Felix-lauscher , Kate-conway , Bristol-myers-squibb , Arthur-rouill , Henry-wheeler , Sandrine-guendoul , Nathalie-pham

Innate Pharma SA: Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology

Sanofi gains exclusive license to Innate's B7H3 ANKETTM program and options for two additional targets; Upon candidate selection, Sanofi will be responsible for all development, manufacturing and

France , French , Eva-schaefer-jansen , Corentine-driancourt , Valeria-fantin , Felix-lauscher , Kate-conway , Bristol-myers-squibb , Arthur-rouill , Henry-wheeler , Sandrine-guendoul , Nathalie-pham

Sanofi gains license to Innate's NK cell therapeutics program

The $26.6 million deal further expands Sanofi and Innate's partnership in developing natural killer cell therapies.

France , French , Valeria-fantin , Innate-pharma , Yannis-morel ,

Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology

Sanofi (NASDAQ: SNY) and Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) announced today an expansion of their collaboration, with Sanofi licensing a natural killer (NK) cell engager program targeting B7H3 from Innate’s ANKETTM (Antibody-based NK Cell Engager Therapeutics) platform. Sanofi will also have the ...

Paris , France-general- , France , French , Valeria-fantin , Bristol-myers-squibb , Novo-nordisk , Astrazeneca , Global-head-of-oncology-research-at-sanofi , Nasdaq , Euronext , Innate-pharma